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Structured abstract 26 
Background: Inhaled natural rubber latex (NRL) allergens in a healthcare environment can 27 
cause NRL sensitization and reduce pulmonary functions. 28 
Objectives: To determine the amount of proteins and the effects of NRL gloves on the 29 
pulmonary functions of female nurses in two hospitals in the southern Thailand. 30 
Methods: The study included 340 female nurses from two hospitals in which self-reported 31 
information and a blood sample was collected. NRL sensitization was determined by using a 32 
solid-phase enzyme-labeled fluoroenzyme-immunoassay for anti-NRL IgE antibodies. 33 
Proteins in NRL gloves were measured by a modified Lowry method. Pulmonary function was 34 
measured by a spirometer. 35 
Results: The prevalences of respiratory effects self-attributed to NRL glove use and of NRL 36 
sensitization were 6.5 and 4.7%, respectively. Four of the 16 sensitized nurses reported 37 
respiratory symptoms. NRL sensitized nurses had lower forced expiratory flow (FEF25-75% 38 
predicted value) than those who were non-sensitized (Adj. difference = -12.56, 95% CI = -39 
24.41 to - 0.70). Furthermore, examination gloves contained protein levels in the range of 111 40 
– 250 mg/dm2. Difference types of NRL glove contained with different amount of proteins. 41 
NRL sensitization was more prevalent in nurses with high concentrations of proteins in NRL 42 
gloves (p = 0.04). 43 
Conclusion: Sensitization to NRL was associated with a decrease in FEF25 - 75% predicted 44 
value, indicating narrowing of the small airways of the lung. Use of gloves with low proteins 45 
can reducing NRL allergen exposure in these hospitals, which may reduce the risk of 46 
developing respiratory problems and NRL sensitization. 47 





  Using powdered latex gloves (PLGs) at work can result in Healthcare workers (HCWs) 51 
having a high risk of exposure to latex allergens.1  Cornstarch powder on PLGs has been 52 
reported as an natural rubber latex (NRL) allergen carrier.2  NRL allergens in powdered gloves 53 
can spread out as airborne particles in workplaces during the wearing and removing of PLGs.3 54 
A high concentration of NRL allergenic proteins has been found in NRL gloves; particularly 55 
in PLGs.1,4 In hospitals where a high concentration of NRL aeroallergen was detected, HCWs 56 
were more likely to have symptoms, including runny nose, wheezing, shortness of breath, 57 
rhinitis, rhino-conjunctivitis and asthma5-8 with a prevalence ranging between 2.3-4.8% of 58 
HCWs.7,8 59 
  NRL allergy remains an occupational health concern, particularly in HCWsin 60 
developing countries such as Thailand due to the high cost of alternatives such as synthetic and 61 
powder-free gloves.9,10In 2017, a study of NRL glove used in a university hospital in Thailand 62 
reported that PLG was mostly used in health care workers (95.6%), while less than 3 percent 63 
of them used nirile gloves, powder free gloves and neoprene gloves.8Furthermore, numerous 64 
medical instruments, such as surgical and examination gloves, catheters,  blood pressure cuffs, 65 
tourniquests, stethoscopes, elastic bandages and wraps, containing NRL are also used in 66 
hospitals4,11and high levels of NRL protein allergens have been reported inmedical gloves, 67 
particularly PLGs.12,13 HCWs who wear PLGs can be exposed to NRL protein allergens by 68 
cutaneous and/or respiratory routes.14-16Such exposure can induce respiratory symptoms in 69 
NRL sensitized individuals.17 70 
  Changes in pulmonary function (e.g. a reduced FEV1) have been described.
18 71 
Respiratory reactions have been reported to occur even in those workers who no longer wear 72 
NRL gloves, but who stayed in the environment where PLGs were used.6  In a study amongst 73 
HCWs in the USA, NRL sensitized HCWs were more likely to leave employment within 2 74 
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years when compared with HCWs who were not sensitized to NRL.19Hence there are 75 
significant health implications to the continuing use of PLGs in Thailand. 76 
There is little information about the prevalence of health effects and on risk factors 77 
specifically related to NRL allergy in Thai HCWs, and so the aim of this study was to evaluate 78 
the amount of crude water soluble proteins in NRL gloves used in hospitals and to determine 79 
the effects of occupational use of NRL gloves on the pulmonary function and NRL sensitization 80 
of nurses in two tertiary hospitals in Thailand. 81 
 82 
Methods 83 
Study design and population.  84 
An analytical observational study was conducted among 664 female nurses working in 85 
two tertiary hospitals in the south of Thailand. All nurses wore NRL gloves at work. The study 86 
was approved by the hospital human right committees from two hospitals (Ref. 87 
YL0027.102/17050 and Ref. SK0027.103/93) and the ethics committee of The University of 88 
Manchester (ref. 08117).This study was approved by Thai Clinical Trial Registry (TCTR: 89 
20190605004). The information sheet and consent form were distributed to nurses before the 90 
study began. Three hundred forty participating nurses had signed in the consent form to confirm 91 
that they all agreed to take part of this study.  92 
 93 
Questionnaire  94 
Information on personal demographics (i.e. personal lifestyle), health status (i.e. history 95 
of ill-health, symptoms related to NRL gloves use) and occupational factors (i.e. working 96 
conditions and use of NRL gloves) was collected using a self-completed questionnaire. This 97 
questionnaire was translated to Thai language and back-translated into English by a second bi-98 
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lingual researcher to ensure consistency and the clarity of translation. The content validity was 99 
considered by three experts. The index of item objective congruence (IOC) was 0.92. 100 
Spirometry 101 
Spirometry was measured using an electronic spirometer (Micro Medical MicroLab 102 
3500, Cardinal Health, UK) using standard procedures and calibrated using normal values for 103 
the population of Thailand.20 Before the test, personal information such as age, weight and 104 
height were recorded. Nurses were asked to sit in a convenient position, take a deep breath and 105 
blow into a spirometer. This was repeated 3 times, and the best of three acceptable blows 106 
(largest value) was recorded. The forced expiratory volume at one second (FEV1) and forced 107 
vital capacity (FVC) were based on the maximal inspiration and expiration of the subjects. The 108 
forced expiratory flow (FEF) 25 – 75 was also recorded. The expected values were based on the 109 
age, sex and height of the subjects.  110 
 111 
Detection of Anti-NRL Immunoglobulin E (IgE)Antibodies 112 
Nurses provided 5 ml of blood. These samples were centrifuged (4,000g) at room 113 
temperature for 15 minutes, the serum separated and transferred into microcentrifuge tubes. 114 
Serum levels of anti-NRL IgE antibody was measured using a solid-phase enzyme-labelled 115 
fluoroenzyme immunoassay (NRL UniCAP Specific IgE Assay) in which allergens are 116 
covalently linked to high-binding-capacity sponge matrices. Specific IgE antibodies present in 117 
serum react with the NRL allergens and non-specific IgE antibodies are removed by washing 118 
the matrices. Enzyme labeled antibodies against IgE antibodies are then added, followed by 119 
developing reagents. Fluorescence was measured and antibody levels determined using a 120 
calibration curve. A positive IgE antibody on NRL was a result > 35 kUA/I.
21 121 
 122 
Determination of protein levels in NRL Glove Extracts 123 
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Two types of NRL gloves most used in medical procedures were selected for testing, 124 
namely powdered examination gloves (PEGs) and powdered surgical gloves (PSGs). Each type 125 
of NRL glove used in hospital 1 and 2 was produced by different glove companies. Crude water 126 
soluble proteins of these gloves were extracted and quantified by using a Modified Lowry 127 
method (the standard of The American Society for Testing Materials (ASTM) test D5712-2005 128 
protocol).22 Briefly, proteins from PLGs were extracted into aqueous buffer solution for pH 7.4 129 
± 0.2and then precipitated with sodium deoxycholate to concentrate them and to separate them 130 
from water soluble substances. The proteins were then redissolved in alkali and quantified 131 
colorimetrically by a Modified Lowry method. Spectrophotometric measurement was 132 
performed at a wavelength of 750 nm. The concentrations of protein in NRL gloves were 133 
reported in microgram per gram (µg/g) of NRL glove. The sensitivity of this method is 50 134 
µg/g.23 135 
 136 
Statistical Analysis 137 
Exploratory data analyses were conducted using frequency tables. Continuous data 138 
were described using mean, median, standard deviation, minimum and maximum values. Chi-139 
square tests were used to analyse the difference in categorical variables. Fisher’s exact test was 140 
used to analyse for small cell counts (n < 5). Mann Whitney U tests were used to analyse data 141 
when the assumption of the t-test was not met. Analysis of covariance (ANCOVA) was used 142 
to analyse effects of sensitization to latex on pulmonary functions. Statistical significance was 143 
considered when p-values were lower than 0.05.  144 
 145 
Results 146 
Of 664 nurses, 340 (51.2% response rate) completed the questionnaires, underwent a 147 
blood test and also spirometry. Detectable levels of IgE antibodies to NRL were found in 4.7% 148 
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of participating (16 of 340 nurses). The demographics of this population were described in 149 
Table 1. There were border significant differences on age and work period between NRL 150 
sensitised and non-sensitised nurses (p = 0.07). 151 
 152 
Respiratory symptoms and pulmonary function  153 
Of 340 nurses, 22 nurses (6.5%) reported respiratory symptoms related to NRL gloves 154 
used. Of 16 nurses with NRL sensitization, 4 sensitised nurses (25%) had reported respiratory 155 
symptoms related to NRL gloves used. The respiratory symptoms included sneezing, rhinitis, 156 
shortness of breath, wheezing and asthma.NRL-sensitized nurses had lower FEF25 – 75% 157 
predicted values than non-sensitized nurses (Adjusted difference = -12.56 (95%CI -24.41 to -158 
0.70); Table 2).  159 
 160 
Use of NRL glove and level of proteins in NRL gloves  161 
The results showed that PEGs had higher proteins than PSGs and there were different 162 
amount of protein levels in PEGs and PSGs between hospital 1 and 2.Theproteinlevels were 163 
found in PEGs in the range of 111.1 – 250.8 ug/dm2, while the NRL sterile gloves were found 164 
proteins in the range of 115.1 – 203.9 ug/dm2. Moreover, there were significant differences in 165 
the levels of proteins of PEGs and PSGs between hospital 1 and 2 (Mean difference (95%CI) 166 
= 139.76 (112.53 to 166.99) and 88.82 (64.19 to 113.44), respectively). According to the 167 
consequence above, high latex sensitisation was found in the hospital where NRL gloves with 168 
high protein levels were used (6.9%vs 2.4%, p = 0.04). Furthermore, the latex sensitised nurses 169 
working in hospital 1where used NRL gloves with high proteins had reported respiratory 170 
symptoms, while the NRL sensitised nurses in hospital 2 where used NRL gloves with low 171 





High levels of water soluble proteins were found PLGs, particularly PEGs. However, 175 
it has been showed that the low water soluble protein level was found in powder free 176 
examination glove, as a study in Germany had evaluated the amount of proteins from powdered 177 
free gloves using a modified Lowry method. The results showed that 13 of 18 powder free 178 
gloves contained protein between 7.1 and 92.3 µg protein/g, while another 5 gloves were found 179 
under detection limit.25 The German technical standards for hazardous material (TRGS 540) 180 
has been recommended that protein levels of  NRL glove should be less than 30 µg 181 
proteins/g.24,25 According to the results in this current study, level of proteins in PLGs was 182 
eight times higher than the recommend value.  183 
The prevalence of NRL sensitisation was higher where PLGs of high protein content 184 
were used to suggest an association between the two. This result supported the findings of a 185 
previous study which reported a decrease of NRL sensitisation and allergic symptoms related 186 
to NRL glove use when low protein NRL gloves were used in hospital workplaces.26 For the 187 
respiratory symptoms which had found in 4 sensitised nurses, all of them worked in the hospital 188 
1 where NRL gloves with high water soluble protein levels were used, while sensitized nurses 189 
in Hospital 2 where NRL gloves with low water soluble protein level were used. This may 190 
assume that NRL glove with a high protein level had also had a high level of NRL allergens. 191 
As, a previous study found that PEGs has highly released an amount of NRL aeroallergens 192 
which 68% of released particles sized was in the range of particle meter between 2.5 and 10 193 
micron, and also 56% NRL aeroallergens were carried on them.27 194 
Exposure to NRL allergens among sensitized nurses in this study was associated with a 195 
decline in pulmonary function, particularly the FEF25 -75% predicted value, while there was no 196 
evidence of effect on the other pulmonary functions. The FEF 25-75% is a parameter which is 197 
more reflective of small airways and sensitive indicator of symptomatic asthma.28 Another 198 
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study on FEF25 – 75 in Italy reported that the abnormal FEF25 – 75 was an early marker of airflow 199 
limitation and it had also suggested that the FEF25-75 can be a predictive marker of newly 200 
diagnosed asthma.29 It also has been reported that the reduced FEF25-75 (<65% of predicted 201 
value) was associated with bronchial hyperreactivity.30 FEF25 – 75could be used to predict 202 
airway hyper responsiveness in adult patient with asthma.  Low FEF25 – 75% predicted value can 203 
show that there was decreased function in the small airways of the lung. However, FEF25 - 75% 204 
predicted values are not specific for small airway diseases,31 but is a sensitive indicator for 205 
airway obstruction.32 FEF25- 75% predicted value is more sensitive than FEV1 in detecting 206 
peripheral or small airway narrowing in adults33as well as identifying individuals with 207 
asymptomatic asthma.34A previous study on the clinical diagnosis of asthma and FEF25-75% 208 
predicted value has been compared the baseline FEF25-75% predicted value using the subsequent 209 
methacholine bronchial provocation test and the results on FEF 25-75%predicted value in patients 210 
with positive bronchial provocation test had significantly lower that patient with normal 211 
responsive airway (t = 4.616, p < 0.001).35 The change of small airways may be one of initially 212 
presenting parameters of a respiratory reaction in NRL sensitized nurses who worked in the 213 
environment with PLG use.  214 
In the past years, there had numerous articles about NRL allergy in health care workers 215 
and also the study of NRL allergens in NRL gloves and other NRL products. Various types of 216 
glove used had different levels of proteins. These proteins were contained with NRL allergens 217 
inducing NRL sensitization in the health care workers. In developing countries as Thailand, 218 
the PLGs were widely used in hospitals for a long time until now.There were few studies about 219 
NRL allergy from NRL gloves exposed in Thai health care workers and no report for the 220 
proteins extracted from NRL glove and NRL sensitization (anti-NRL IgE antibodies) in Thai 221 
nurses. This current study revealed more information on the NRL sensitization, amount of 222 
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glove proteins, respiratory symptoms and pulmonary functions in nurses working in 223 
governmental hospitals. 224 
The limitations of this study were that the voluntary participation may have resulted in 225 
volunteer bias in that nurses who reported health problems may have been overrepresented 226 
compared to nurses who were healthy.  Furthermore, the healthy worker effects may be found 227 
in this study due to some evidences showed that non-sensitised nurse are older and have worked 228 
longer than sensitized nurses. The sensitized nurses might change their job positions due to 229 
health problems related to gloves used before the study was done. This study collected the self-230 
reported data of respiratory symptoms related to gloves used, but fixed choice questions may 231 
lack flexibility and forces to answer and also social desirability bias may occur. The self-232 
reported symptoms may occur not only expose to NRL allergens, but also chemical and powder 233 
cornstarch from PLGs. The design of this study cannot derive causal relationship between 234 
pulmonary function and proteins of NRL glove exposure and NRL sensitization. Furthermore, 235 
the confounding factors such as secondary smoking, underlying lung disease or allergic 236 
diseases may affect the result of pulmonary function test.  237 
In conclusion, there was moderate evidence that exposure to NRL airborne allergens in 238 
the healthcare sector can affect pulmonary function of sensitized workers as measured by FEF25 239 
– 75% predicted value. The evidences in this study revealed exposure to high level protein in 240 
NRL glove has affected the respiratory and the low FEF25-75 % predicted value where found in 241 
sensitized nurses. This suggests that it is important to minimize the level of NRL aeroallergens 242 
in the workplace environment by using powder free gloves or synthetic latex free gloves, which 243 
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Table 1. Characteristics of nurses  346 
Variable All nurses 
(n = 340) 
Latex sensitized 
cases 
(n = 16) 
Non-latex 
sensitized cases 
(n = 324) 
P-value 
Age (years)    0.07a 
Mean ± SD 36.9 ± 8.3 33.1 ± 8.2 37.1 ± 8.3 
 Median 35.0 33.0 35.0 
Min-Max 23.0 – 60.0 23 - 48 23 - 60 
BMI classification, n (%)    0.49 a 
Mean ± SD 22.1± 3.4 22.3± 2.9 22.1± 3.4 
 Median 21.4 22.4 21.36 
Min-Max 116.0-34.5 17.9-30.3 16.0 – 34.5 
Education, n (%)    1.00 
Diploma  16 (4.7) 1 (6.3) 15 (4.6) 
 
Bachelor and over 292 (85.9) 14 (87.5) 278 (85.5) 
Ethnicity, n (%)    
0.54c Thai 269 (79.1) 14 (87.5) 255 (78.7) 
Thai-Chinese/Malaysian   71 (20.9)   2 (12.5) 69 (21.3) 
Non-Smoker, n (%) 340 (100.0) 16 (100.0) 324 (100.0) - 
Personal history of allergic 
disease (Y/N, % yes) 
134/206 (39.4) 5/11 (31.3) 129/195 (39.8) 0.494 b 
Type of personal allergic disease     
Hay fever (Y/N, % yes) 36/304 (10.6) 2/14 (12.5) 34/290 (10.5) 0.682 c 
Grass allergy (Y/N, % yes) 31/309 (9.1) 2/14 (12.5) 29/295 (9.0) 0.648 c 
Eczema (Y/N, % yes) 56/284 (16.5) 1/15 (6.3) 55/269 (17.0) 0.487 c 
16 
 
Hives (Y/N, % yes) 91/249 (26.8) 3/13 (18.8) 88/236 (27.2) 0.573 c 
Asthma (Y/N, % yes) 16/324 (4.7) 2/14 (12.5) 14/310 (4.3) 0.170 c 
Autoimmune (Y/N, % yes) 5/335 (1.5) 0/16 (0.0) 5/319 (1.5) 1.000 c 
Atopy (Y/N, % yes) 87/253 (25.6) 3/13 (18.8) 84/240 (25.9) 0.770 c 
Family history of allergic diseases 
(Y/N, % yes) 
153/187 (45.0) 8/8 (50.0) 145/179 (44.8) 0.680 b 
Type of family allergic disease     
Hay fever (Y/N, % yes) 37/303 (10.9) 3/13(18.8) 34/290 (10.5) 0.398 c 
Grass allergy (Y/N, % yes) 29/311 (8.5) 2/14 (12.5) 27/297 (8.3) 0.636 c 
Eczema (Y/N, % yes) 65/275 (19.1) 2/14 (12.5) 63/261 (19.4) 0.746 c 
Hives (Y/N, % yes) 84/256 (24.7) 3/13 (18.8) 81/243 (25.0) 0.769 c 
Asthma (Y/N, % yes) 67/273 (19.7) 2/14 (12.5) 65/259 (20.1) 0.747 c 
Autoimmune (Y/N, % yes) 9/331 (2.6) 1/15 (6.3) 8/316 (2.5) 0.355 c 
Atopy (Y/N, % yes) 122/218 (35.9) 6/10 (37.5) 116/208 (35.8) 1.000 c 
Position, n (%)    
0.57 b    Registered nurses 323 (95.0) 15 (93.8) 308 (95.1) 
   Practical or Technical nurses 17 (5.0) 1 (6.3) 16 (4.9) 
Workplace, n (%)     
OPD  31 (9.1) 0 (0.0) 31 (9.6) - 
ER  19 (5.6) 0 (0.0) 19 (5.9)  
ICU  60 (17.6) 1 (6.3) 59 (18.2)  
OR 50 (14.7)  2 (12.5) 48 (14.8)  
LR 23 (6.8)  3 (18.8) 20 (6.2)  
Sur 74 (21.8) 4 (25.0) 70 (21.6)  
Obs 33 (9.7) 4 (25.0) 29 (9.0)  
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Med 50 (14.7) 2 (12.5) 48 (14.8)  
Work period      
   Mean ± SD 14.7 ± 8.5 11.0 ± 8.1 14.9 ±8.5 
0.07 b    Median 13.0 10.9 13.0 
   Min-Max 0.7 – 36.0 0.8 – 24.1 0.7 - 36 
Work shift, n (%)     
≤ 35 hours/week 133 (39.2) 5 (31.3) 128 (39.6) 0.61 b 
> 35 hours/week 206 (60.8) 11 (68.8) 195 (60.4)  
aP-value by Mann-Whitney U Test; bP-value by using Chi-Square Test; cP-value by using 347 





















(n = 16) 
Non-sensitized 
(n = 324) P-value 
Adj.difference 
(95% CI) 
Mean ± SD Mean ± SD 
FEV1 (L) 2.21 ± 0.20 2.24 ± 0.35 0.62
a - 0.04 (-0.19 to 0.11) 
FVC (L) 2.51 ± 0.30 2.51 ± 0.40 0.95a 0.01 (-0.17 to 0.18) 
FEV1/FVC ratio 88.3 ± 4.7 89.7 ± 5.5 0.28
a - 1.51 (- 4.23 to 1.21) 
FEV1 (% predicted) 90.7 ± 10.2 91.8 ± 12.1 0.74
b - 1.01 (-7.03 to 5.01) 
FVC (% predicted) 90.3 ± 11.5 89.0 ± 12.3 0.69b 1.26 (-4.86 to 7.37) 
FEF25% -75%predicted 83.3± 17.0 95.8 ± 23.8 0.04
b - 12.56 (- 24.41 to -0.70)) 
aAdjusted for age, height, and weight using ANCOVA;  bAdjusted for weight using 365 
ANCOVA; FEV1: Force expiration volume in one second; FVC: Force volume capacity; 366 













Table 3.Comparison of number of NRL glove used, total proteins in NRL gloves, latex 378 
sensitisation and respiratory symptoms in latex sensitised nurses between hospital 1 and 379 
2 380 
Variable Hospital 1 
Mean ± SD 
Hospital 2 




-Average number of 
NRL examination glove 
used per day 
9.97 ± 9.54 9.17 ± 9.34 
0.80 
(-1.36 to 2.96) 
0.467 
-Average number of 
NRL surgical glove 
used per day 
6.77 ± 9.41 6.36 ± 7.29 
0.41 
(-1.71 to 2.54) 
0.698 
-Average total protein 
of powdered 
examination gloves 
(ug/dm2) ± SD 
250.8 ± 16.00 111.1 ± 5.60 139.76 
(112.53 to 166.99) 
<0.001 
-Average total protein 
of powdered surgical 
gloves (ug/dm2) ± SD 
203.9 ± 13.00 115.1 ± 8.20 88.82 
(64.19 to 113.44) 
0.001 
-Latex sensitization(%) 6.9 2.4  0.048 
-Respiratory symptoms 
in latex sensitized 
nurses (n=4) 
4 0  - 
P-value by Independent t test 381 
 382 
 383 
20 
 
 384 
